Ingevity financials
$71.06−2.31%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $314.1M | $258.0M | $255.1M | $333.1M | $331.5M | $247.9M | $263.3M | $333.8M | $390.6M | $340.1M | $371.7M | $446.0M |
| Gross profit | $139.0M | $116.4M | $87.8M | $133.9M | $127.8M | $111.9M | $99.9M | $131.6M | $123.2M | $99.7M | $59.5M | $129.0M |
| Gross margin | 44.3% | 45.1% | 34.4% | 40.2% | 38.6% | 45.1% | 37.9% | 39.4% | 31.5% | 29.3% | 16.0% | 28.9% |
| Operating income | $64.9M | $46.1M | -$73.2M | $81.8M | -$118.0M | $57.0M | $45.0M | $84.3M | -$287.5M | -$17.1M | -$131.5M | $55.3M |
| Net income | $35.3M | $59.8M | -$84.6M | $43.5M | -$146.5M | $20.5M | $16.6M | -$107.2M | -$283.7M | -$56.0M | -$116.8M | $25.2M |
| Net margin | 11.2% | 23.2% | −33.2% | 13.1% | −44.2% | 8.3% | 6.3% | −32.1% | −72.6% | −16.5% | −31.4% | 5.7% |
| Diluted EPS | $1.00 | $1.66 | $-2.43 | $1.18 | $-4.02 | $0.56 | $0.46 | $-2.94 | $-7.81 | $-1.54 | $-3.29 | $0.69 |
| EBITDA | $120.7M | $69.3M | $66.7M | $110.8M | $98.6M | $83.8M | $80.3M | $113.7M | $101.8M | $75.3M | -$10.7M | $110.5M |
| Operating cash flow | -$13.8M | -$2.0M | $97.1M | $129.7M | $79.0M | $25.4M | $64.5M | $46.5M | $29.7M | -$12.1M | $46.2M | $105.2M |
| Free cash flow | -$24.1M | -$12.3M | $73.5M | $117.8M | $66.8M | $15.4M | $39.6M | $28.5M | $11.6M | -$28.7M | $17.0M | $71.7M |
| Diluted shares | 35.3M | 36.0M | 34.8M | 37.0M | 36.5M | 36.7M | 36.2M | 36.5M | 36.3M | 36.3M | 36.3M | 36.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $97.4M | $95.4M | $78.1M | $83.4M | $76.9M | $71.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.20B | $1.20B | $1.21B | $1.26B | $1.33B | $1.39B |
| Total assets | $1.54B | $1.65B | $1.65B | $1.83B | $1.88B | $2.06B |
| Total liabilities | $1.49B | $1.61B | $1.62B | $1.70B | $1.76B | $1.82B |
| Shareholders' equity | $46.9M | $38.9M | $29.7M | $138.1M | $120.7M | $234.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology